

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.49563622 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.98508009 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 4.98508009 |
| 4 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.52626991 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.46255479 |
| 6 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.15073693 |
| 7 | synaptic vesicle maturation (GO:0016188) | 3.90582735 |
| 8 | erythrocyte maturation (GO:0043249) | 3.77768068 |
| 9 | positive thymic T cell selection (GO:0045059) | 3.71338257 |
| 10 | pre-miRNA processing (GO:0031054) | 3.58615126 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.54185490 |
| 12 | peptidyl-lysine dimethylation (GO:0018027) | 3.52230469 |
| 13 | modulation by symbiont of host cellular process (GO:0044068) | 3.47246509 |
| 14 | erythrocyte development (GO:0048821) | 3.41321698 |
| 15 | regulation of response to osmotic stress (GO:0047484) | 3.40041460 |
| 16 | oxygen transport (GO:0015671) | 3.39542859 |
| 17 | regulation of ARF protein signal transduction (GO:0032012) | 3.37459923 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.36328597 |
| 19 | negative regulation of cell killing (GO:0031342) | 3.36328597 |
| 20 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.32511990 |
| 21 | positive regulation of histone deacetylation (GO:0031065) | 3.32217871 |
| 22 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.30038328 |
| 23 | modulation by virus of host process (GO:0019054) | 3.29866154 |
| 24 | positive T cell selection (GO:0043368) | 3.29231646 |
| 25 | hemoglobin metabolic process (GO:0020027) | 3.28273188 |
| 26 | protein retention in ER lumen (GO:0006621) | 3.28144106 |
| 27 | regulation of RNA export from nucleus (GO:0046831) | 3.27851811 |
| 28 | thymic T cell selection (GO:0045061) | 3.27005884 |
| 29 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.26291611 |
| 30 | sodium ion export (GO:0071436) | 3.25464067 |
| 31 | glandular epithelial cell development (GO:0002068) | 3.24774772 |
| 32 | cellular response to virus (GO:0098586) | 3.23885092 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.17538159 |
| 34 | positive regulation of nuclease activity (GO:0032075) | 3.16947369 |
| 35 | embryonic process involved in female pregnancy (GO:0060136) | 3.16867284 |
| 36 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.13232217 |
| 37 | locomotory exploration behavior (GO:0035641) | 3.12050905 |
| 38 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.09907054 |
| 39 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.09329778 |
| 40 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08662591 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.06437821 |
| 42 | regulation of early endosome to late endosome transport (GO:2000641) | 3.05530903 |
| 43 | type B pancreatic cell development (GO:0003323) | 3.03386022 |
| 44 | histone H3-K36 demethylation (GO:0070544) | 3.01818097 |
| 45 | gas transport (GO:0015669) | 3.01675066 |
| 46 | regulation of ARF GTPase activity (GO:0032312) | 3.01099778 |
| 47 | neutrophil activation involved in immune response (GO:0002283) | 3.01071639 |
| 48 | response to peptidoglycan (GO:0032494) | 3.00115362 |
| 49 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.98471528 |
| 50 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.97835022 |
| 51 | pinocytosis (GO:0006907) | 2.96297746 |
| 52 | signal complex assembly (GO:0007172) | 2.93501541 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.92251772 |
| 54 | regulation of chromatin binding (GO:0035561) | 2.91642562 |
| 55 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.89241379 |
| 56 | regulation of nuclease activity (GO:0032069) | 2.88727954 |
| 57 | regulation of necroptotic process (GO:0060544) | 2.87673661 |
| 58 | cellular hyperosmotic response (GO:0071474) | 2.87189825 |
| 59 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.86658087 |
| 60 | T cell selection (GO:0045058) | 2.85749322 |
| 61 | mitotic chromosome condensation (GO:0007076) | 2.85360534 |
| 62 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.83151487 |
| 63 | negative regulation of cell size (GO:0045792) | 2.82541366 |
| 64 | positive regulation of Rap GTPase activity (GO:0032854) | 2.81366478 |
| 65 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.80858048 |
| 66 | regulation of defense response to virus by virus (GO:0050690) | 2.80715957 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80380802 |
| 68 | nuclear pore complex assembly (GO:0051292) | 2.80334494 |
| 69 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.79183041 |
| 70 | vesicle coating (GO:0006901) | 2.78495813 |
| 71 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.77407545 |
| 72 | histone H2A monoubiquitination (GO:0035518) | 2.77068449 |
| 73 | negative T cell selection (GO:0043383) | 2.76328985 |
| 74 | negative regulation of necroptotic process (GO:0060546) | 2.74594939 |
| 75 | germinal center formation (GO:0002467) | 2.72613102 |
| 76 | stress granule assembly (GO:0034063) | 2.69886452 |
| 77 | negative thymic T cell selection (GO:0045060) | 2.69061209 |
| 78 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.67936230 |
| 79 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66821334 |
| 80 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.63305638 |
| 81 | corticosteroid receptor signaling pathway (GO:0031958) | 2.61672287 |
| 82 | regulation of histone H3-K27 methylation (GO:0061085) | 2.59990701 |
| 83 | histone H4-K12 acetylation (GO:0043983) | 2.58706003 |
| 84 | heme biosynthetic process (GO:0006783) | 2.58623284 |
| 85 | megakaryocyte development (GO:0035855) | 2.58100178 |
| 86 | DNA unwinding involved in DNA replication (GO:0006268) | 2.57759754 |
| 87 | pentose-phosphate shunt (GO:0006098) | 2.57090666 |
| 88 | mRNA stabilization (GO:0048255) | 2.54935724 |
| 89 | RNA stabilization (GO:0043489) | 2.54935724 |
| 90 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.54359372 |
| 91 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.52540970 |
| 92 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.52183726 |
| 93 | cellular response to arsenic-containing substance (GO:0071243) | 2.52086249 |
| 94 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.51495922 |
| 95 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.51211405 |
| 96 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.50506094 |
| 97 | myeloid cell development (GO:0061515) | 2.50339940 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 2.50315091 |
| 99 | activation of MAPKKK activity (GO:0000185) | 2.50243648 |
| 100 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.48467051 |
| 101 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.48131786 |
| 102 | porphyrin-containing compound metabolic process (GO:0006778) | 2.47742269 |
| 103 | negative regulation of viral release from host cell (GO:1902187) | 2.47523289 |
| 104 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.47047015 |
| 105 | granulocyte activation (GO:0036230) | 2.46272920 |
| 106 | tetrapyrrole biosynthetic process (GO:0033014) | 2.46184429 |
| 107 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.45929988 |
| 108 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45929988 |
| 109 | positive regulation by symbiont of host defense response (GO:0052509) | 2.45422536 |
| 110 | modulation by symbiont of host defense response (GO:0052031) | 2.45422536 |
| 111 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.45422536 |
| 112 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.45422536 |
| 113 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.45422536 |
| 114 | modulation by symbiont of host immune response (GO:0052553) | 2.45422536 |
| 115 | regulation of superoxide anion generation (GO:0032928) | 2.44435253 |
| 116 | regulation of Rap GTPase activity (GO:0032317) | 2.44060836 |
| 117 | negative regulation of histone methylation (GO:0031061) | 2.42563986 |
| 118 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.41950785 |
| 119 | pore complex assembly (GO:0046931) | 2.41554943 |
| 120 | protein export from nucleus (GO:0006611) | 2.40634747 |
| 121 | epithelial cell fate commitment (GO:0072148) | 2.40629991 |
| 122 | granulocyte differentiation (GO:0030851) | 2.40413702 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.40274544 |
| 124 | response to arsenic-containing substance (GO:0046685) | 2.39801077 |
| 125 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.39456398 |
| 126 | macrophage activation involved in immune response (GO:0002281) | 2.38957414 |
| 127 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38358065 |
| 128 | T cell migration (GO:0072678) | 2.38219595 |
| 129 | definitive hemopoiesis (GO:0060216) | 2.37876974 |
| 130 | cellular response to unfolded protein (GO:0034620) | 2.36974238 |
| 131 | layer formation in cerebral cortex (GO:0021819) | 2.36829838 |
| 132 | activation of protein kinase A activity (GO:0034199) | 2.34929353 |
| 133 | positive regulation of lamellipodium assembly (GO:0010592) | 2.34571436 |
| 134 | positive regulation of RNA splicing (GO:0033120) | 2.34123023 |
| 135 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.32585709 |
| 136 | histone H3-K4 methylation (GO:0051568) | 2.32404182 |
| 137 | histone H4-K16 acetylation (GO:0043984) | 2.32299138 |
| 138 | regulation of synaptic vesicle transport (GO:1902803) | 2.32025117 |
| 139 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.30696849 |
| 140 | localization within membrane (GO:0051668) | 2.29647781 |
| 141 | COPII vesicle coating (GO:0048208) | 2.29571477 |
| 142 | vesicle transport along microtubule (GO:0047496) | 2.29469106 |
| 143 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.29027047 |
| 144 | protein localization to endosome (GO:0036010) | 2.27855765 |
| 145 | ER-nucleus signaling pathway (GO:0006984) | 2.26718824 |
| 146 | tolerance induction (GO:0002507) | 2.26478495 |
| 147 | peptidyl-threonine phosphorylation (GO:0018107) | 2.26295535 |
| 148 | positive regulation of protein deacetylation (GO:0090312) | 2.26273119 |
| 149 | protein maturation by protein folding (GO:0022417) | 2.25428597 |
| 150 | peptidyl-threonine modification (GO:0018210) | 2.25172012 |
| 151 | NADPH regeneration (GO:0006740) | 2.24537453 |
| 152 | cellular response to topologically incorrect protein (GO:0035967) | 2.24062855 |
| 153 | positive regulation of lamellipodium organization (GO:1902745) | 2.23744752 |
| 154 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.23700911 |
| 155 | nuclear pore organization (GO:0006999) | 2.22303203 |
| 156 | regulation of mast cell degranulation (GO:0043304) | 2.21417228 |
| 157 | regulation of erythrocyte differentiation (GO:0045646) | 2.21208420 |
| 158 | regulation of leukocyte degranulation (GO:0043300) | 2.20749175 |
| 159 | insulin secretion (GO:0030073) | 2.20619853 |
| 160 | NLS-bearing protein import into nucleus (GO:0006607) | 2.20460124 |
| 161 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.20104303 |
| 162 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.19693479 |
| 163 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.19524927 |
| 164 | dosage compensation (GO:0007549) | 2.19078552 |
| 165 | negative regulation of GTPase activity (GO:0034260) | 2.18691681 |
| 166 | negative regulation of GTP catabolic process (GO:0033125) | 2.18691681 |
| 167 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.18535606 |
| 168 | negative regulation of meiosis (GO:0045835) | 2.18260327 |
| 169 | glycosphingolipid catabolic process (GO:0046479) | 2.17625612 |
| 170 | regulation of chronic inflammatory response (GO:0002676) | 2.17332632 |
| 171 | histone lysine demethylation (GO:0070076) | 2.16612516 |
| 172 | cell communication by electrical coupling (GO:0010644) | 2.16568411 |
| 173 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.16528238 |
| 174 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.16227376 |
| 175 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.15403179 |
| 176 | histone H4-K8 acetylation (GO:0043982) | 2.15182105 |
| 177 | histone H4-K5 acetylation (GO:0043981) | 2.15182105 |
| 178 | histone demethylation (GO:0016577) | 2.14919860 |
| 179 | negative regulation of glial cell proliferation (GO:0060253) | 2.14894445 |
| 180 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.14865588 |
| 181 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.14651199 |
| 182 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.14547015 |
| 183 | nerve growth factor signaling pathway (GO:0038180) | 2.14414896 |
| 184 | stress fiber assembly (GO:0043149) | 2.13153613 |
| 185 | cerebellar Purkinje cell layer development (GO:0021680) | 2.11988096 |
| 186 | cellular potassium ion homeostasis (GO:0030007) | 2.11962039 |
| 187 | intestinal epithelial cell development (GO:0060576) | 2.11865886 |
| 188 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.11267343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.08184966 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.07475900 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.11516670 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.90087002 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84700358 |
| 6 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.84402272 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.78185149 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.75681152 |
| 9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.73789797 |
| 10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.67688033 |
| 11 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.56881767 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.56183520 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41997001 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.41743246 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.40308179 |
| 16 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.29063143 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.27702300 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.25183270 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11591408 |
| 20 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.09829714 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07327482 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.05265690 |
| 23 | * KDM2B_26808549_Chip-Seq_K562_Human | 2.05074741 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00898482 |
| 25 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.97169456 |
| 26 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.93859591 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.91861538 |
| 28 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.91145775 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87003209 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81625021 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80737589 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.78584150 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77308590 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71299752 |
| 35 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.69659946 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.68915976 |
| 37 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.62965816 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62731832 |
| 39 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.62049365 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61927481 |
| 41 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.60635905 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.59591210 |
| 43 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.59496408 |
| 44 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.58421140 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58227285 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.58010534 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57871907 |
| 48 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.57265664 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57011460 |
| 50 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.56710920 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55579794 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55057893 |
| 53 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.52427103 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51445175 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.49919231 |
| 56 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.49728964 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48688815 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.48348463 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.44547338 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.44222730 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.43124954 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.43084374 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41425929 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38217153 |
| 65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37725089 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37104451 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36164640 |
| 68 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.36138683 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35360824 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34913155 |
| 71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33958379 |
| 72 | * MYB_26560356_Chip-Seq_TH2_Human | 1.33550290 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32872993 |
| 74 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31159225 |
| 75 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.30733038 |
| 76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30693004 |
| 77 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27715871 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26745146 |
| 79 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26447370 |
| 80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25249227 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24713599 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24214305 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24159944 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22427819 |
| 85 | * MYB_26560356_Chip-Seq_TH1_Human | 1.22255392 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20197974 |
| 87 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.20115197 |
| 88 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19954500 |
| 89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19241903 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18873640 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18431934 |
| 92 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.18301390 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17754765 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17403698 |
| 95 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17384605 |
| 96 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.17152072 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16827490 |
| 98 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16730342 |
| 99 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16112394 |
| 100 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.15655787 |
| 101 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15509348 |
| 102 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.15384985 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.13992173 |
| 104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12899557 |
| 105 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12586370 |
| 106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12272083 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12122663 |
| 108 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.10867512 |
| 109 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09994414 |
| 110 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07187453 |
| 111 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07066449 |
| 112 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.06820752 |
| 113 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06682369 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.06477641 |
| 115 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06334066 |
| 116 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.05819178 |
| 117 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05152427 |
| 118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04515086 |
| 119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03334408 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02420521 |
| 121 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01586537 |
| 122 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01289133 |
| 123 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01054396 |
| 124 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.00798695 |
| 125 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00782571 |
| 126 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00294714 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99726541 |
| 128 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99138844 |
| 129 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98777329 |
| 130 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98314426 |
| 131 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.98148017 |
| 132 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97875246 |
| 133 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.97850065 |
| 134 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97544461 |
| 135 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97309726 |
| 136 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97083985 |
| 137 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96695236 |
| 138 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96616847 |
| 139 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.96487133 |
| 140 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96411816 |
| 141 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.96106453 |
| 142 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95682902 |
| 143 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.95151258 |
| 144 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94666943 |
| 145 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94445756 |
| 146 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93568709 |
| 147 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93286257 |
| 148 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.92904747 |
| 149 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.92395102 |
| 150 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91595179 |
| 151 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90709102 |
| 152 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90325885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.36462682 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 4.00548098 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.31834903 |
| 4 | MP0003283_abnormal_digestive_organ | 3.23386266 |
| 5 | MP0008961_abnormal_basal_metabolism | 3.07263382 |
| 6 | MP0003436_decreased_susceptibility_to | 2.80326443 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 2.68112722 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.60952284 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.53450285 |
| 10 | MP0002909_abnormal_adrenal_gland | 2.44691371 |
| 11 | MP0002653_abnormal_ependyma_morphology | 2.35999704 |
| 12 | MP0004147_increased_porphyrin_level | 2.21654571 |
| 13 | MP0005083_abnormal_biliary_tract | 2.21056536 |
| 14 | MP0008260_abnormal_autophagy | 2.19620931 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.17452168 |
| 16 | MP0001545_abnormal_hematopoietic_system | 2.17452168 |
| 17 | MP0009840_abnormal_foam_cell | 2.16140473 |
| 18 | MP0004947_skin_inflammation | 2.14178014 |
| 19 | MP0001849_ear_inflammation | 2.10152548 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.07630786 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.06806468 |
| 22 | MP0000678_abnormal_parathyroid_gland | 2.00896543 |
| 23 | MP0003787_abnormal_imprinting | 1.96163748 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.93411266 |
| 25 | MP0002693_abnormal_pancreas_physiology | 1.92456664 |
| 26 | MP0004858_abnormal_nervous_system | 1.86226014 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.85835219 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.83332921 |
| 29 | MP0004264_abnormal_extraembryonic_tissu | 1.82047747 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.81914271 |
| 31 | MP0009785_altered_susceptibility_to | 1.81186647 |
| 32 | MP0004043_abnormal_pH_regulation | 1.81070020 |
| 33 | MP0004233_abnormal_muscle_weight | 1.77428432 |
| 34 | MP0005025_abnormal_response_to | 1.75598987 |
| 35 | MP0001944_abnormal_pancreas_morphology | 1.75082652 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.74392010 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.74336066 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.73099381 |
| 39 | MP0002419_abnormal_innate_immunity | 1.71176616 |
| 40 | MP0003303_peritoneal_inflammation | 1.69745981 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 1.64203919 |
| 42 | MP0003866_abnormal_defecation | 1.63232434 |
| 43 | MP0004270_analgesia | 1.61023796 |
| 44 | MP0005310_abnormal_salivary_gland | 1.60562497 |
| 45 | MP0005387_immune_system_phenotype | 1.55871930 |
| 46 | MP0001790_abnormal_immune_system | 1.55871930 |
| 47 | MP0000858_altered_metastatic_potential | 1.55451566 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.54353343 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.52948782 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.51843088 |
| 51 | MP0001819_abnormal_immune_cell | 1.49502102 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.49437762 |
| 53 | MP0000003_abnormal_adipose_tissue | 1.49390143 |
| 54 | MP0001853_heart_inflammation | 1.47838506 |
| 55 | MP0009278_abnormal_bone_marrow | 1.47139389 |
| 56 | MP0001800_abnormal_humoral_immune | 1.46658618 |
| 57 | MP0002723_abnormal_immune_serum | 1.45471147 |
| 58 | MP0008057_abnormal_DNA_replication | 1.41609981 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.39555183 |
| 60 | MP0002405_respiratory_system_inflammati | 1.38998799 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.38820645 |
| 62 | MP0004510_myositis | 1.37321157 |
| 63 | MP0002132_abnormal_respiratory_system | 1.36398285 |
| 64 | MP0003635_abnormal_synaptic_transmissio | 1.35293262 |
| 65 | MP0002429_abnormal_blood_cell | 1.33425526 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.32701753 |
| 67 | MP0003119_abnormal_digestive_system | 1.28437254 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.27811355 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.22400350 |
| 70 | MP0008569_lethality_at_weaning | 1.19235916 |
| 71 | MP0006082_CNS_inflammation | 1.12694926 |
| 72 | MP0003693_abnormal_embryo_hatching | 1.11730222 |
| 73 | MP0004811_abnormal_neuron_physiology | 1.11176951 |
| 74 | MP0003646_muscle_fatigue | 1.10853606 |
| 75 | MP0005501_abnormal_skin_physiology | 1.09775419 |
| 76 | MP0003045_fibrosis | 1.09488001 |
| 77 | MP0002084_abnormal_developmental_patter | 1.09289935 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 1.09179625 |
| 79 | MP0001873_stomach_inflammation | 1.08577538 |
| 80 | MP0004885_abnormal_endolymph | 1.08080900 |
| 81 | MP0002796_impaired_skin_barrier | 1.07805799 |
| 82 | MP0002398_abnormal_bone_marrow | 1.05655621 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.05151490 |
| 84 | MP0001730_embryonic_growth_arrest | 1.03706159 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 1.03227336 |
| 86 | MP0000313_abnormal_cell_death | 1.03215892 |
| 87 | MP0002234_abnormal_pharynx_morphology | 1.01971508 |
| 88 | MP0000490_abnormal_crypts_of | 1.01463336 |
| 89 | MP0003091_abnormal_cell_migration | 1.00354642 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.99660649 |
| 91 | MP0001915_intracranial_hemorrhage | 0.99325672 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.99202303 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.98792969 |
| 94 | MP0003890_abnormal_embryonic-extraembry | 0.98056782 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.97454065 |
| 96 | MP0000604_amyloidosis | 0.96619676 |
| 97 | MP0009703_decreased_birth_body | 0.96389626 |
| 98 | MP0000955_abnormal_spinal_cord | 0.95963068 |
| 99 | MP0002063_abnormal_learning/memory/cond | 0.94760037 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.94483110 |
| 101 | MP0005646_abnormal_pituitary_gland | 0.93328643 |
| 102 | MP0009931_abnormal_skin_appearance | 0.93256202 |
| 103 | MP0002085_abnormal_embryonic_tissue | 0.93125400 |
| 104 | MP0009672_abnormal_birth_weight | 0.92867229 |
| 105 | MP0003724_increased_susceptibility_to | 0.92741032 |
| 106 | MP0003121_genomic_imprinting | 0.92432189 |
| 107 | MP0000343_altered_response_to | 0.91560312 |
| 108 | MP0008877_abnormal_DNA_methylation | 0.90365026 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.90361146 |
| 110 | MP0005384_cellular_phenotype | 0.88417392 |
| 111 | MP0003075_altered_response_to | 0.88250788 |
| 112 | MP0003448_altered_tumor_morphology | 0.88135099 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.85847117 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.85705308 |
| 115 | MP0009333_abnormal_splenocyte_physiolog | 0.85653023 |
| 116 | MP0009763_increased_sensitivity_to | 0.85648660 |
| 117 | MP0000350_abnormal_cell_proliferation | 0.85427041 |
| 118 | MP0003122_maternal_imprinting | 0.85101873 |
| 119 | MP0001697_abnormal_embryo_size | 0.84051353 |
| 120 | MP0003111_abnormal_nucleus_morphology | 0.83969918 |
| 121 | MP0005220_abnormal_exocrine_pancreas | 0.83913919 |
| 122 | MP0000462_abnormal_digestive_system | 0.83839554 |
| 123 | MP0010094_abnormal_chromosome_stability | 0.83615098 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.83542462 |
| 125 | MP0002733_abnormal_thermal_nociception | 0.83179421 |
| 126 | MP0008469_abnormal_protein_level | 0.82895253 |
| 127 | MP0010307_abnormal_tumor_latency | 0.82544548 |
| 128 | MP0003329_amyloid_beta_deposits | 0.81858405 |
| 129 | MP0002166_altered_tumor_susceptibility | 0.81488293 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.81363571 |
| 131 | MP0003566_abnormal_cell_adhesion | 0.80019996 |
| 132 | MP0008007_abnormal_cellular_replicative | 0.79876379 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.79511484 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.79357640 |
| 135 | MP0005380_embryogenesis_phenotype | 0.78606463 |
| 136 | MP0001672_abnormal_embryogenesis/_devel | 0.78606463 |
| 137 | MP0003123_paternal_imprinting | 0.78273082 |
| 138 | MP0003705_abnormal_hypodermis_morpholog | 0.77868002 |
| 139 | MP0002086_abnormal_extraembryonic_tissu | 0.77824867 |
| 140 | MP0003984_embryonic_growth_retardation | 0.77073290 |
| 141 | MP0005645_abnormal_hypothalamus_physiol | 0.76937448 |
| 142 | MP0002088_abnormal_embryonic_growth/wei | 0.75638615 |
| 143 | MP0002080_prenatal_lethality | 0.73520882 |
| 144 | MP0000371_diluted_coat_color | 0.72366869 |
| 145 | MP0010234_abnormal_vibrissa_follicle | 0.70527164 |
| 146 | MP0001502_abnormal_circadian_rhythm | 0.69458594 |
| 147 | MP0000733_abnormal_muscle_development | 0.68968541 |
| 148 | MP0005671_abnormal_response_to | 0.67934798 |
| 149 | MP0003077_abnormal_cell_cycle | 0.67582594 |
| 150 | MP0000716_abnormal_immune_system | 0.67125262 |
| 151 | MP0000428_abnormal_craniofacial_morphol | 0.65943716 |
| 152 | MP0002722_abnormal_immune_system | 0.65542852 |
| 153 | MP0003879_abnormal_hair_cell | 0.65482375 |
| 154 | MP0000685_abnormal_immune_system | 0.65403155 |
| 155 | MP0005621_abnormal_cell_physiology | 0.64978997 |
| 156 | MP0001970_abnormal_pain_threshold | 0.64629267 |
| 157 | MP0008770_decreased_survivor_rate | 0.64573131 |
| 158 | MP0002928_abnormal_bile_duct | 0.64553455 |
| 159 | MP0010155_abnormal_intestine_physiology | 0.64411896 |
| 160 | MP0005058_abnormal_lysosome_morphology | 0.64249094 |
| 161 | MP0002269_muscular_atrophy | 0.63825808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.75672189 |
| 2 | Reticulocytosis (HP:0001923) | 4.23045032 |
| 3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.72105613 |
| 4 | Hyperacusis (HP:0010780) | 3.61200194 |
| 5 | Poikilocytosis (HP:0004447) | 3.57406077 |
| 6 | Papilledema (HP:0001085) | 3.38524974 |
| 7 | Cholecystitis (HP:0001082) | 3.36884289 |
| 8 | Abnormal gallbladder physiology (HP:0012438) | 3.36884289 |
| 9 | Cholelithiasis (HP:0001081) | 3.24622691 |
| 10 | Polycythemia (HP:0001901) | 3.24367178 |
| 11 | Recurrent viral infections (HP:0004429) | 3.19487088 |
| 12 | Autoimmune hemolytic anemia (HP:0001890) | 3.16329094 |
| 13 | Abnormality of the fingertips (HP:0001211) | 3.09548815 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.01584241 |
| 15 | Abnormality of reticulocytes (HP:0004312) | 2.99707900 |
| 16 | Eczematoid dermatitis (HP:0000976) | 2.91109792 |
| 17 | Macroorchidism (HP:0000053) | 2.90472524 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 2.78194773 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.77051765 |
| 20 | Abnormal gallbladder morphology (HP:0012437) | 2.74576731 |
| 21 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.74491200 |
| 22 | Visual hallucinations (HP:0002367) | 2.72610288 |
| 23 | Hypertensive crisis (HP:0100735) | 2.69352118 |
| 24 | Insomnia (HP:0100785) | 2.67826809 |
| 25 | Slow saccadic eye movements (HP:0000514) | 2.61522601 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 2.56501466 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.51061167 |
| 28 | Abnormality of the lower motor neuron (HP:0002366) | 2.49011099 |
| 29 | Neoplasm of the heart (HP:0100544) | 2.46414193 |
| 30 | Large for gestational age (HP:0001520) | 2.44374360 |
| 31 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.41760108 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37776172 |
| 33 | Elfin facies (HP:0004428) | 2.32314696 |
| 34 | Ependymoma (HP:0002888) | 2.29888117 |
| 35 | Increased IgM level (HP:0003496) | 2.29673476 |
| 36 | Microcytic anemia (HP:0001935) | 2.28330200 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.28127726 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.28127726 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.28127726 |
| 40 | Obstructive lung disease (HP:0006536) | 2.28021373 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28021373 |
| 42 | Abnormality of the astrocytes (HP:0100707) | 2.27966955 |
| 43 | Astrocytoma (HP:0009592) | 2.27966955 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.27538223 |
| 45 | Hand muscle atrophy (HP:0009130) | 2.25728611 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.25485912 |
| 47 | Increased serum ferritin (HP:0003281) | 2.24604617 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24395363 |
| 49 | Fatigue (HP:0012378) | 2.22955221 |
| 50 | Male infertility (HP:0003251) | 2.22772793 |
| 51 | Hypercortisolism (HP:0001578) | 2.22639405 |
| 52 | Pointed chin (HP:0000307) | 2.21506321 |
| 53 | Abnormality of the gallbladder (HP:0005264) | 2.20731591 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.19106884 |
| 55 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.17257039 |
| 56 | Acanthocytosis (HP:0001927) | 2.17249044 |
| 57 | Papillary thyroid carcinoma (HP:0002895) | 2.17146414 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.16188485 |
| 59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16188485 |
| 60 | Peripheral hypomyelination (HP:0007182) | 2.15804360 |
| 61 | Recurrent fungal infections (HP:0002841) | 2.15684303 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15628526 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15628526 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15628526 |
| 65 | Renal duplication (HP:0000075) | 2.15477314 |
| 66 | Unilateral renal agenesis (HP:0000122) | 2.14865817 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.14794158 |
| 68 | Cellulitis (HP:0100658) | 2.14103131 |
| 69 | Termporal pattern (HP:0011008) | 2.11989608 |
| 70 | Insidious onset (HP:0003587) | 2.11989608 |
| 71 | Hypochromic anemia (HP:0001931) | 2.09022723 |
| 72 | Urticaria (HP:0001025) | 2.08484654 |
| 73 | Increased IgE level (HP:0003212) | 2.07955911 |
| 74 | Diaphragmatic weakness (HP:0009113) | 2.07780575 |
| 75 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.06568476 |
| 76 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.06568476 |
| 77 | Overriding aorta (HP:0002623) | 2.06536894 |
| 78 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04870182 |
| 79 | Deep palmar crease (HP:0006191) | 2.04664092 |
| 80 | Loss of speech (HP:0002371) | 2.04595098 |
| 81 | Orthostatic hypotension (HP:0001278) | 2.03383826 |
| 82 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.02950198 |
| 83 | Tetraparesis (HP:0002273) | 2.02881610 |
| 84 | Abnormal hemoglobin (HP:0011902) | 2.02871482 |
| 85 | Nasal polyposis (HP:0100582) | 2.01275247 |
| 86 | Ileus (HP:0002595) | 2.00760471 |
| 87 | Bundle branch block (HP:0011710) | 2.00341365 |
| 88 | Pustule (HP:0200039) | 1.99741948 |
| 89 | Supranuclear gaze palsy (HP:0000605) | 1.99400543 |
| 90 | Paralysis (HP:0003470) | 1.96856319 |
| 91 | IgA deficiency (HP:0002720) | 1.96520467 |
| 92 | Broad palm (HP:0001169) | 1.94246895 |
| 93 | Distal upper limb amyotrophy (HP:0007149) | 1.94098669 |
| 94 | Upper limb amyotrophy (HP:0009129) | 1.94098669 |
| 95 | Abnormality of T cells (HP:0002843) | 1.94095988 |
| 96 | Stomatitis (HP:0010280) | 1.93870861 |
| 97 | Hypoglycemic seizures (HP:0002173) | 1.93824187 |
| 98 | Apathy (HP:0000741) | 1.91905953 |
| 99 | Granulocytopenia (HP:0001913) | 1.91601130 |
| 100 | Bowel incontinence (HP:0002607) | 1.91186274 |
| 101 | Abnormal large intestine physiology (HP:0012700) | 1.90936905 |
| 102 | Colitis (HP:0002583) | 1.90071115 |
| 103 | Prominent metopic ridge (HP:0005487) | 1.89920295 |
| 104 | Dysostosis multiplex (HP:0000943) | 1.89299875 |
| 105 | Meningitis (HP:0001287) | 1.89147560 |
| 106 | Amyotrophic lateral sclerosis (HP:0007354) | 1.89113118 |
| 107 | Gastrointestinal infarctions (HP:0005244) | 1.87528138 |
| 108 | Ankyloglossia (HP:0010296) | 1.87080520 |
| 109 | Seborrheic dermatitis (HP:0001051) | 1.86932564 |
| 110 | Abnormality of the thoracic spine (HP:0100711) | 1.86431283 |
| 111 | Progressive external ophthalmoplegia (HP:0000590) | 1.85591025 |
| 112 | Vasculitis (HP:0002633) | 1.85085723 |
| 113 | Genetic anticipation (HP:0003743) | 1.85013969 |
| 114 | Gastrointestinal inflammation (HP:0004386) | 1.84873893 |
| 115 | Neuronal loss in central nervous system (HP:0002529) | 1.84594835 |
| 116 | Diminished motivation (HP:0000745) | 1.83937883 |
| 117 | Volvulus (HP:0002580) | 1.83919766 |
| 118 | Hyperbilirubinemia (HP:0002904) | 1.83725725 |
| 119 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.83377203 |
| 120 | Heterotopia (HP:0002282) | 1.83218368 |
| 121 | Abnormality of oral frenula (HP:0000190) | 1.82564011 |
| 122 | Orchitis (HP:0100796) | 1.82189982 |
| 123 | Spinal canal stenosis (HP:0003416) | 1.80955065 |
| 124 | Epistaxis (HP:0000421) | 1.80737702 |
| 125 | Severe short stature (HP:0003510) | 1.79696586 |
| 126 | Impaired smooth pursuit (HP:0007772) | 1.79209448 |
| 127 | Annular pancreas (HP:0001734) | 1.79080027 |
| 128 | Neurofibrillary tangles (HP:0002185) | 1.78425958 |
| 129 | Dysmetric saccades (HP:0000641) | 1.77843042 |
| 130 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.77717150 |
| 131 | Abnormality of iron homeostasis (HP:0011031) | 1.77528956 |
| 132 | Neoplasm of the oral cavity (HP:0100649) | 1.77270903 |
| 133 | Osteomyelitis (HP:0002754) | 1.76383052 |
| 134 | Basal cell carcinoma (HP:0002671) | 1.75711601 |
| 135 | Abnormality of T cell physiology (HP:0011840) | 1.75598726 |
| 136 | Arterial thrombosis (HP:0004420) | 1.75567269 |
| 137 | Impaired platelet aggregation (HP:0003540) | 1.75475982 |
| 138 | Abnormal platelet function (HP:0011869) | 1.75475982 |
| 139 | Long palpebral fissure (HP:0000637) | 1.75081832 |
| 140 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74916669 |
| 141 | Recurrent skin infections (HP:0001581) | 1.74320833 |
| 142 | T lymphocytopenia (HP:0005403) | 1.73857910 |
| 143 | Viral hepatitis (HP:0006562) | 1.73759503 |
| 144 | Ventricular fibrillation (HP:0001663) | 1.73676618 |
| 145 | Increased nuchal translucency (HP:0010880) | 1.73491949 |
| 146 | Decreased circulating renin level (HP:0003351) | 1.72439413 |
| 147 | Entropion (HP:0000621) | 1.71832283 |
| 148 | Myocardial infarction (HP:0001658) | 1.71761802 |
| 149 | Prolonged bleeding time (HP:0003010) | 1.71662451 |
| 150 | Personality changes (HP:0000751) | 1.71422704 |
| 151 | Vertebral arch anomaly (HP:0008438) | 1.70940237 |
| 152 | Myositis (HP:0100614) | 1.70499451 |
| 153 | Hepatosplenomegaly (HP:0001433) | 1.70372162 |
| 154 | Renovascular hypertension (HP:0100817) | 1.69934869 |
| 155 | Thin bony cortex (HP:0002753) | 1.69313919 |
| 156 | Obsessive-compulsive behavior (HP:0000722) | 1.69090635 |
| 157 | Depression (HP:0000716) | 1.67637638 |
| 158 | Hyperparathyroidism (HP:0000843) | 1.67615302 |
| 159 | Subacute progressive viral hepatitis (HP:0006572) | 1.67507382 |
| 160 | Decreased motor nerve conduction velocity (HP:0003431) | 1.67017437 |
| 161 | Vacuolated lymphocytes (HP:0001922) | 1.66656101 |
| 162 | Thoracic kyphosis (HP:0002942) | 1.66649739 |
| 163 | Abnormality of the metopic suture (HP:0005556) | 1.66039510 |
| 164 | Inflammation of the large intestine (HP:0002037) | 1.65569394 |
| 165 | Sacral dimple (HP:0000960) | 1.65052873 |
| 166 | Symptomatic seizures (HP:0011145) | 1.63237749 |
| 167 | Truncal obesity (HP:0001956) | 1.62370699 |
| 168 | Chest pain (HP:0100749) | 1.58463848 |
| 169 | Ankle clonus (HP:0011448) | 1.58219434 |
| 170 | Long toe (HP:0010511) | 1.56838190 |
| 171 | Bowel diverticulosis (HP:0005222) | 1.56521432 |
| 172 | Aneurysm (HP:0002617) | 1.55602749 |
| 173 | Villous atrophy (HP:0011473) | 1.55348080 |
| 174 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.55348080 |
| 175 | Hypercalciuria (HP:0002150) | 1.55233753 |
| 176 | Abnormality of the nasal mucosa (HP:0000433) | 1.54181274 |
| 177 | Obstructive sleep apnea (HP:0002870) | 1.53268378 |
| 178 | Abnormality of T cell number (HP:0011839) | 1.50236905 |
| 179 | Intellectual disability, profound (HP:0002187) | 1.50045479 |
| 180 | Spinal muscular atrophy (HP:0007269) | 1.49822266 |
| 181 | Failure to thrive in infancy (HP:0001531) | 1.48812579 |
| 182 | Adrenal overactivity (HP:0002717) | 1.48135082 |
| 183 | Tented upper lip vermilion (HP:0010804) | 1.47992237 |
| 184 | Ureteral stenosis (HP:0000071) | 1.47583784 |
| 185 | Hemiplegia (HP:0002301) | 1.47306609 |
| 186 | Myokymia (HP:0002411) | 1.45998990 |
| 187 | Prominent nose (HP:0000448) | 1.45988988 |
| 188 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.45128126 |
| 189 | Frequent falls (HP:0002359) | 1.44432015 |
| 190 | Glioma (HP:0009733) | 1.43962510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.94583277 |
| 2 | TRIB3 | 3.64993070 |
| 3 | PRKD3 | 3.32687550 |
| 4 | EEF2K | 3.13820633 |
| 5 | IRAK3 | 2.95166040 |
| 6 | PKN2 | 2.62172216 |
| 7 | TAOK1 | 2.61413535 |
| 8 | CDK12 | 2.60741901 |
| 9 | PASK | 2.49553479 |
| 10 | TAOK2 | 2.40429309 |
| 11 | MAP2K3 | 2.20906894 |
| 12 | ICK | 2.19062353 |
| 13 | MAP3K14 | 2.18272385 |
| 14 | MAP3K9 | 2.10807003 |
| 15 | SMG1 | 2.09139483 |
| 16 | KSR2 | 2.08440402 |
| 17 | RIPK4 | 2.07796565 |
| 18 | MAP3K10 | 2.07067154 |
| 19 | TYRO3 | 1.98260191 |
| 20 | EIF2AK1 | 1.97515340 |
| 21 | HIPK2 | 1.97318464 |
| 22 | PAK6 | 1.90744171 |
| 23 | MAP4K1 | 1.88120342 |
| 24 | NME2 | 1.83600794 |
| 25 | ALK | 1.73554631 |
| 26 | SIK2 | 1.72737993 |
| 27 | PDGFRA | 1.63500830 |
| 28 | LATS2 | 1.62444516 |
| 29 | ERN1 | 1.57544252 |
| 30 | PRKCH | 1.54303547 |
| 31 | TAOK3 | 1.51769894 |
| 32 | MARK2 | 1.51085863 |
| 33 | SCYL2 | 1.47038316 |
| 34 | TBK1 | 1.45653471 |
| 35 | MAP3K3 | 1.45004957 |
| 36 | LATS1 | 1.43636606 |
| 37 | MATK | 1.41766161 |
| 38 | RIPK1 | 1.39042087 |
| 39 | IRAK4 | 1.34778577 |
| 40 | PIM1 | 1.29472605 |
| 41 | DMPK | 1.27538947 |
| 42 | PRKD2 | 1.22678863 |
| 43 | NTRK1 | 1.21532985 |
| 44 | STK38 | 1.19828344 |
| 45 | CAMKK1 | 1.17404143 |
| 46 | PTK6 | 1.17185674 |
| 47 | MAP3K6 | 1.17095489 |
| 48 | CLK1 | 1.16786815 |
| 49 | RET | 1.16739142 |
| 50 | UHMK1 | 1.12222994 |
| 51 | TYK2 | 1.11679898 |
| 52 | NTRK3 | 1.04011906 |
| 53 | IKBKE | 1.03134077 |
| 54 | MAP3K2 | 1.02998437 |
| 55 | FGR | 1.01524199 |
| 56 | BMPR2 | 1.00906152 |
| 57 | MTOR | 1.00033965 |
| 58 | MAP3K7 | 0.97358187 |
| 59 | ZAP70 | 0.96719282 |
| 60 | MAP3K8 | 0.96440940 |
| 61 | MAP3K1 | 0.96440226 |
| 62 | MARK1 | 0.95639602 |
| 63 | JAK3 | 0.95132079 |
| 64 | BTK | 0.94123016 |
| 65 | MAP3K5 | 0.94063262 |
| 66 | BMX | 0.92579162 |
| 67 | ITK | 0.91854373 |
| 68 | MAP3K13 | 0.90682780 |
| 69 | NEK2 | 0.89597493 |
| 70 | IKBKB | 0.89006948 |
| 71 | RAF1 | 0.85942745 |
| 72 | TTK | 0.85916422 |
| 73 | CDK6 | 0.85010748 |
| 74 | PTK2 | 0.84130067 |
| 75 | SIK1 | 0.83625747 |
| 76 | NTRK2 | 0.83226336 |
| 77 | CDC42BPA | 0.83206620 |
| 78 | STK10 | 0.82779535 |
| 79 | FLT3 | 0.81150884 |
| 80 | KSR1 | 0.80545523 |
| 81 | SRPK1 | 0.78608589 |
| 82 | INSRR | 0.77742814 |
| 83 | SGK3 | 0.77405277 |
| 84 | CDK4 | 0.77151027 |
| 85 | CAMK1D | 0.76863031 |
| 86 | DAPK1 | 0.74495279 |
| 87 | TESK1 | 0.74332925 |
| 88 | PDGFRB | 0.74246485 |
| 89 | IRAK2 | 0.70185779 |
| 90 | JAK1 | 0.69921044 |
| 91 | JAK2 | 0.69780608 |
| 92 | SYK | 0.69255744 |
| 93 | GRK6 | 0.68954705 |
| 94 | PAK4 | 0.67310081 |
| 95 | MAP3K4 | 0.66585394 |
| 96 | MAPKAPK2 | 0.63588475 |
| 97 | MOS | 0.61859980 |
| 98 | TXK | 0.61795702 |
| 99 | WNK1 | 0.61471216 |
| 100 | STK11 | 0.60705191 |
| 101 | NEK1 | 0.60687788 |
| 102 | SIK3 | 0.60449300 |
| 103 | DAPK2 | 0.59993413 |
| 104 | STK4 | 0.59814343 |
| 105 | DYRK3 | 0.59005549 |
| 106 | MAPK15 | 0.58702476 |
| 107 | RPS6KA2 | 0.58515843 |
| 108 | CHUK | 0.58302292 |
| 109 | BRD4 | 0.58151895 |
| 110 | DDR2 | 0.57718745 |
| 111 | PDK1 | 0.56806773 |
| 112 | EPHA2 | 0.56200388 |
| 113 | PRKAA1 | 0.54871627 |
| 114 | CDK7 | 0.54598835 |
| 115 | TESK2 | 0.52120556 |
| 116 | EPHB1 | 0.50900811 |
| 117 | ARAF | 0.50837653 |
| 118 | PIM2 | 0.50724010 |
| 119 | CSK | 0.48928093 |
| 120 | MAP3K11 | 0.48558051 |
| 121 | CDK5 | 0.48384876 |
| 122 | RPS6KL1 | 0.47416497 |
| 123 | RPS6KC1 | 0.47416497 |
| 124 | LMTK2 | 0.47202018 |
| 125 | RPS6KA4 | 0.46914516 |
| 126 | LYN | 0.44928379 |
| 127 | IRAK1 | 0.44918391 |
| 128 | BLK | 0.44240773 |
| 129 | MAPK11 | 0.43845526 |
| 130 | RPS6KA1 | 0.43431140 |
| 131 | MARK3 | 0.43069883 |
| 132 | MAPK10 | 0.42564561 |
| 133 | MINK1 | 0.41768999 |
| 134 | CAMK1G | 0.41620955 |
| 135 | HCK | 0.40540021 |
| 136 | CHEK1 | 0.40281195 |
| 137 | CHEK2 | 0.39523249 |
| 138 | CDK9 | 0.39439227 |
| 139 | FGFR3 | 0.38191753 |
| 140 | EPHA3 | 0.37761320 |
| 141 | TNK2 | 0.37755214 |
| 142 | CDK2 | 0.37726652 |
| 143 | DYRK1B | 0.37009359 |
| 144 | FGFR4 | 0.35778611 |
| 145 | PAK3 | 0.35707300 |
| 146 | LRRK2 | 0.34339419 |
| 147 | MAPK8 | 0.32890250 |
| 148 | MAPK14 | 0.32746656 |
| 149 | PRKD1 | 0.32670446 |
| 150 | PDPK1 | 0.32507450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.34727875 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.17956009 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.01717447 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00706124 |
| 5 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.96344381 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 1.87757472 |
| 7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.81108392 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 1.71523414 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.70895969 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.66415381 |
| 11 | Apoptosis_Homo sapiens_hsa04210 | 1.62713823 |
| 12 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57256277 |
| 13 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56404804 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.55911863 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55440263 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.49953143 |
| 17 | Hepatitis C_Homo sapiens_hsa05160 | 1.45771507 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45693950 |
| 19 | Endometrial cancer_Homo sapiens_hsa05213 | 1.44071969 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.43560543 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.41865202 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.39735251 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.37470452 |
| 24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.34526542 |
| 25 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32780442 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31867875 |
| 27 | Colorectal cancer_Homo sapiens_hsa05210 | 1.30703716 |
| 28 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.29997283 |
| 29 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.26384322 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.24373133 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24163846 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23962751 |
| 33 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.22812250 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.22235143 |
| 35 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.21139651 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21049251 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19600471 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18473879 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16960492 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16692416 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.16292629 |
| 42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.16176137 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15788303 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.14920634 |
| 45 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.14157795 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.14077091 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13873049 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11630018 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.11248806 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10746313 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07495977 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07216461 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06813304 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.05942527 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.05780080 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04330646 |
| 57 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.04172289 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03890227 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.03206129 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.03087532 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02293856 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.01711609 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00265774 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99800177 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99467015 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98914781 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98906793 |
| 68 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98020820 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.97672170 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97508135 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.96524758 |
| 72 | Cell cycle_Homo sapiens_hsa04110 | 0.95158700 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94536984 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.93996930 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93854369 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93203484 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.92572760 |
| 78 | Spliceosome_Homo sapiens_hsa03040 | 0.92417911 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92383215 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.92175238 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90728638 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90446496 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90306232 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90243084 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.89818535 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89613148 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.89114323 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88191307 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88111994 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87520439 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86988566 |
| 92 | DNA replication_Homo sapiens_hsa03030 | 0.86658793 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.85153562 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84734886 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83139580 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82991889 |
| 97 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.82049156 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80764090 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80528836 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80410793 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80400311 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78651945 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77703714 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.77540609 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.77216361 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.77176249 |
| 107 | Adherens junction_Homo sapiens_hsa04520 | 0.76904443 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76573808 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73911446 |
| 110 | Morphine addiction_Homo sapiens_hsa05032 | 0.73844185 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.73781990 |
| 112 | Hepatitis B_Homo sapiens_hsa05161 | 0.73561825 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73155680 |
| 114 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72907546 |
| 115 | Allograft rejection_Homo sapiens_hsa05330 | 0.72771356 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72710436 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72031128 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71841913 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71305600 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70966390 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70745689 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70617607 |
| 123 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.70341539 |
| 124 | Gap junction_Homo sapiens_hsa04540 | 0.69924879 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69440609 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68768301 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.68745425 |
| 128 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68327549 |
| 129 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68026045 |
| 130 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67578008 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67461586 |
| 132 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67181014 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67024812 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66130055 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65722946 |
| 136 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64685509 |
| 137 | GABAergic synapse_Homo sapiens_hsa04727 | 0.64124443 |
| 138 | Long-term depression_Homo sapiens_hsa04730 | 0.63766692 |
| 139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62174379 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.62003732 |
| 141 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61658784 |
| 142 | Prostate cancer_Homo sapiens_hsa05215 | 0.61225634 |
| 143 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60794767 |
| 144 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60553227 |
| 145 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.60428217 |
| 146 | Shigellosis_Homo sapiens_hsa05131 | 0.60059143 |
| 147 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59656166 |
| 148 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59606411 |
| 149 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59139951 |
| 150 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57458201 |
| 151 | Salivary secretion_Homo sapiens_hsa04970 | 0.56819345 |
| 152 | Melanogenesis_Homo sapiens_hsa04916 | 0.56612387 |
| 153 | Base excision repair_Homo sapiens_hsa03410 | 0.56608702 |
| 154 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56351854 |
| 155 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53681045 |

